Speed and efficiency to help you meet your timelines
Clinical development continues to face increasing complexities, timelines and costs
Biopharmaceutical and biotech drug developers continue to face increasing challenges. Long-standing issues related to increasing complexities, timelines and costs in clinical development are nothing new, but recent trends indicate pressures are escalating, putting greater burdens on sponsors, sites and patients.
And the data supports this:
more procedures in Phase III clinical trials.1
increase in Phase III trial timelines.1
increase in the average cost to bring a new drug to market.2
As a result, drug developers face even more project delays, missed market opportunities, loss of patent protection, regulatory concerns and financial strain.
A single day of delay is worth approximately $500,000 in unrealized or lost prescription drug sales and $40,000 in direct daily clinical trial costs.3
of drug developers are using FSP or hybrid FSP/FSO (full-service outsourcing) solutions.4
Over the past two years, the use of FSP outsourcing has grown faster than FSO
▼
of drug developers increased their use of FSP.4
have increased their use of FSO.4
of sponsors are increasing their use of FSP.5
Not all FSP partners are created equal. Is your FSP partner equipped to:
PPD FSP solutions is the solution
Choosing the right FSP partner is key. The right FSP partner helps drug developers maximize speed and efficiency and employs new and innovative strategies to deliver programs on-time and on-budget.
PPD™ Functional Service Partnership (FSP) solutions help biotech and biopharmaceutical companies meet their timelines by delivering the best of the best: hard-to-find, top-tier staff with a proven track record of reliably delivering clinical development and post-marketing services.
With more than 30 years of support for clinical and marketed products, we know what it takes to solve your specific challenges. Whether you need to fill small gaps in services or outsource multiple functions across a portfolio, we deliver customized solutions tailored to your needs to provide much-needed resource flexibility, reliability and continuity.
Ready to maximize speed and efficiency to meet your timelines? Let’s connect.
Sources
- Tufts CSDD Impact Report Volume 27, Number 6, November/December 2025
- Deloitte, Measuring the return from pharmaceutical innovation, 15th edition March 2025
- How much does a day of delay in a clinical trial really cost?, June 2024, Applied Clinical Trials, Ken Getz, Executive Director and Professor, Tufts University School of Medicine
- The Pulse 2024, Global R&D Insights in Pharmaceuticals, PPD Report
- Complex CRO Environment: Looking at Cascade of Trends – Mega to Macro to Micro, January 2025 Jefferies report